Aerie Pharmaceuticals Inc. (AERI) Has Surged To A New High On Study Results

Aerie Pharmaceuticals Inc. (AERI) announced after the bell Wednesday that its Phase 3 clinical trial of RoclatanTM achieved its primary efficacy endpoint.

from RTT - Hot Stocks http://ift.tt/2ccF73q
via IFTTT